Docs connections below.... Paragon Bioservices,
Post# of 85492
Paragon Bioservices, Inc., the University of Maryland BioPark’s largest tenant and one of its fastest-growing biotechnology companies, is celebrating another success with the announcement that it has entered into a definitive agreement under which Catalent, Inc., a New Jersey-based contract drug manufacturer, will acquire Paragon for $1.2 billion.
https://www.umaryland.edu/news/archived-news/...ired-f.php
CATALENT AND JOHNSON AND JOHNSON WORKING ON NEW VACCINE TOGETHER....
DOC WITH PREISDENT OF umb biopark....